The Effect of RABEX-5 Downregulation on the Chemosensitivity of Human Breast Cancer Cells

ZHANG Xiang, LI Hong-yuan, MIN Jie. et al

Abstract

To investigate the changes in sensitivity to anthracycline and taxanes of human breast cancer cells after RABEX-5 downregulated. Methods By constructing a lentiviral vector for RNA interference (RNAi) of RABEX-5 gene and transfected into human breast cancer cell line MCF-7 to silence the express of RABEX-5. Real-time PCR and Western blot were used to detect the silencing effect. The changes in sensitivity to chemotherapeutic drugs of MCF-7/RNAi and its negative control cell lines MCF-7/vector were detected by CCK-8 reagent. Results Compared with MCF-7 cell and MCF-7/vector cell, the expression of RABEX-5 mRNA and protein was downregulated in MCF-7/RNAi cells. The sensitivity to epirubicin was reduced after downregulating the expression of RABEX-5, the 50% inhibition concentration (IC50) of MCF-7/RNAi 〔(3.590 0±0.228 69) μg/mL〕 was higher than that of MCF-7/Vvector 〔(1.193 3±0.187 71) μg/mL, P50 were (11.162 7±0.210 26) μg/mL and (10.536 7±0.430 97) μg/mL, respectively (P>0.05). Conclusion Downregulation of RABEX-5 can induce chemoresistance to epirubicin in human breast cancer cell MCF-7; while its effect on sensitivity to docetaxel is not significant. This study can provide a theoretical basis for future research RABEX-5 in the individualized treatment of breast cancer.

 

Key words:  RABEX-5 MCF-7, Epirubicin, Docetaxel chemotherapy sensitivity 

 

Full Text:

PDF


References


Jemal A, Bray F, Center MM, el at. Global cancer statistics. CA Cancer J Clin,2011 ;61(2) ;69-90.

Kalesnikoff J, Rios EJ, Chen CC, et al. RabGEFl regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells. Proc Natl Acad Sci U S A, 2006; 103 (8):2659-2664.

Horiuchi H, Lippe R. McBride HM, et al. A novel Rab5 GDP/GTP exchange factor complexed to Rabaptin-5 links nucleotide exchange to effector recruitment and function. Cell, 1997;90(6);1149-1159.

Rubino M, Miaczynska M, Lippe R, et al. Selective membrane recruitment of EEA1 suggests a role in directional transport of clathrin-coated vesicles to early endosomes. J Biol Chem,2000; 275(6):3745-3748.

Nimmrich I, Erdmann S, Melchers U, et al. Seven genes that are differentially transcribed in colorectal tumor cell lines. Cancer Lett,2000;160(1):37-43.

Xu AM, Huang PH. Receptor tyrosine kinase coactivation networks in cancer. Cancer Res,2010;70(10):3857-3860. Pardo OE, Latigo J, Jeffery RE, et al. The fibroblast growth factor receptor inhibitor PD173074 blocks smallcell lung cancer growth in vitro and in vivo. Cancer Res, 2009; 69 ( 22 ) ; 8645- 8651.

Kilbey A, Terry A, Jenkins A, et al. Runx regulation of sphingolipid metabolism and survival signaling. Cancer Res, 2010;70(14):5860-5869.

Singh A, Boldin-Adamsky S, Thimmulappa RK, et al. RNAi- mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increasesefficacy of chemotherapy. Cancer Res, 2008;68(19):7975-7984.

Olive KP, Jacobetz MA, Davidson CJ, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science, 2009 ; 324 ( 5933 ): 1457-1461.


Refbacks

  • There are currently no refbacks.